-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster III

Symposia: Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Man Qiao, MD1*, Suning Chen2*, Ying Wang3*, Shengli Xue4*, Xiaofei Yang5*, Depei Wu, MD, PhD6, Huiying Qiu4*, Yue Han, MD, PhD7*, Yanming Zhang, M.D.8*, Kourong Miao9*, Jihao Zhou, MD, PhD10*, Xiaojin Wu, MD11*, Miao Miao, MD4*, Tao You, M.D., PhD4*, Xiao Ma4* and Haiping Dai12*

1Department of Hematology, National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou, China
2The First Affiliated Hospital of Soochow University, Suzhou, China
3The first Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center of Hematologic Diseases, Suzhou, China
4National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
5National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
6Department of Hematology, The first Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center of Hematologic Diseases, Suzhou, China
7Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China
8Department of Hematology, The Affiliated Huai'an Hospital of Xuzhou Medical University and The Second People's Hospital of Huai'an, Huai'An, China
9People's Hospital of Jiangsu Province, Suzhou, China
10Department of Hematology, Shenzhen People’s Hospital, Shenzhen, China
11The First Affiliated Hospital Of Soochow University, Suzhou, Jiangsu, CHN
12the Leukemia Working Group of National Clinical Research Center for Hematologic Diseases, Suzhou, China

Yves Chalandon1, Edouard F. Bonneville2*, Liesbeth C. de Wreede2*, Linda Koster3*, Joe Tuffnell3*, Jakob Passweg, MD4*, Johannes Schetelig, MD, MSc5, Uwe Platzbecker, MD6,7, Ibrahim Yakoub-Agha, MD, PhD8*, Urpu Salmenniemi, MD9*, Mareike Verbeek, MD10*, Moniek De Witte, MD11*, Jean-Baptiste Méar, MD12*, John Snowden, MD13*, Tobias A.W. Holderried, MD14,15*, Gwendolyn Van Gorkom, MD16*, Frederic Baron17, Marie Robin, MD18*, Xavier Poiré, MD, PhD19*, Mieke Roeven, MD20*, Maija Itälä-Remes, MD, PhD21*, Jan Maciej Zaucha22*, Kavita K Raj, MD, PhD, FRCP, FRCPath23, Joanna Drozd-Sokolowska, MD, PhD24*, Giorgia Battipaglia, MD25*, Nicola Polverelli26, Tomasz Czerw, MD27*, Juan Carlos Hernandez Boluda, MD, PhD28* and Donal P McLornan, MD, PhD29*

1Hematology Service and Faculty of Medicine, University Hospital of Geneva, Geneva, Switzerland
2Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands
3EBMT Leiden Study Unit, Leiden, Netherlands
4University Hospital Basel, Basel, Switzerland
5Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Saxony, Germany
6Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany
7Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany
8CHU de Lille, Université de Lille, INSERM U1286, Infinite, 59000, Lille, France
9HUCH Comprehensive Cancer Center, Helsinki, Finland, Helsinki, Finland
10Department of Medicine III, Hematology and Oncology, Technical University of Munich (TUM), School of Medicine and Health, Munich, Germany
11University Medical Centre Utrecht, Utrecht, NLD
12BMT unit, CHU Rennes, Rennes, France
13Sheffield Blood & Marrow Transplant and Cellular Therapy Programme, Sheffield, United Kingdom
14Universitaetsklinikum Bonn (UKB), Bonn, Germany
15Department of Hematology, Oncology, Stem Cell Transplantation, Immune and Cell Therapy, Clinical Immunology and Rheumatology, University Hospital Bonn, Bonn, Germany
16University Hospital Maastricht, Maastricht, Netherlands
17University of Liege, Liege, Belgium
18Hopital Saint Louis, APHP, Paris, France
19Cliniques Universitaires St. Luc, Brussels, Belgium
20Radboud University Medical Centre, Nijmegen, Netherlands
21Turku University Hospital, Turku, Finland
22Department of Hematology and Transplantology, Medical University of Gdansk and University Clinical Center in Gdansk, Gdansk, Poland
23Department of Haematology, University College London Hospitals NHS Trust, London, United Kingdom
24Medical University of Warsaw, University Clinical Centre, Warsaw, Poland
25Federico II University of Naples, Hematology Department, Naples, Italy
26Unit of Bone Marrow Transplantation – Division of Hematology,, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
27Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, POL
28Hospital Clínico Universitario-INCLIVA, VALENCIA, Spain
29Department of Haematology, University College London Hospitals NHS Trust, London, ENG, United Kingdom

Frederic Baron1, Allain Thibeault Ferhat Berland2*, Myriam Labopin3*, Matthias Eder, MD4*, Alessandro Rambaldi5, Cristina Castilla-Llorente, MD6*, Igor Wolfgang Blau, MD, PhD7*, Francesca Bonifazi8*, Thomas Schroeder9*, Nicolaus Kröger, MD10*, Didier Blaise, MD11*, Peter Dreger12, Tobias Gedde-Dahl13*, Jaime Sanz14*, Mohamad Mohty, MD, PhD15 and Fabio Ciceri, MD16*

1University of Liege, Liege, Belgium
2EBMT Paris study office, Paris, France
3EBMT Statistical Unit, Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMRs 938, Paris, France
4Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
5Department of Oncology-Hematology, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
6Gustave Roussy Cancer Campus, Villejuif, France
7Medizinische Klinik m. S. Hämatologie , Onkologie und Tumorimmunologie, Berlin, Germany, Berlin, Germany
8Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology "Seràgnoli" University of Bologna, Bologna, Italy
9Dept. of Hematology and Stem Cell Transplantation West German Cancer Centre University Hospital Essen Essen, Germany, Essen, Germany
10German Registry for Hematopoietic Stem Cell Transplantation and Cell Therapy (DRST), Ulm, Germany
11Programme de Transplantation & Thérapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Marseille, France
12Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany
13Rikshospitalet, Oslo University Hospital, Oslo, Norway
14Hematology Department, Hospital Universitari i Politècnic La Fe, Departament de Medicina Universitat de Valencia, CIBERONC, Instituto Carlos III, Spain, VALENCIA, Spain
15Sorbonne University, Hôpital Saint-Antoine, and INSERM UMRs938, Paris, France
16Hematology and Bone Marrow Transplantation Unit, I.R.C.C.S. San Raffaele Scientific Institute, Milan, Italy

Nihar Desai, MBBS, MD, DM1*, Tommy Alfaro Moya, MD2*, Arjun Law, MD3,4, Wilson Lam, MD3,5, Igor Novitzky-Basso, MD3,5*, Ivan Pasic, MD3,5*, Fotios Michelis, MD3,5*, Armin Gerbitz, MD, PhD3,6*, Dennis Dong Hwan Kim, MD, PhD3,7, Rajat Kumar, MD PhD3,5, Jonas Mattsson, MD, PhD3,8* and Auro Viswabandya, MD3,6

1Princess Margaret Cancer Center, Lucknow, India
2Princess Margaret Cancer Center, Toronto, Canada
3Department of Medicine, University of Toronto, Toronto, ON, Canada
4Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada, Toronto, Canada
5Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada, Toronto, ON, Canada
6Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
7Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
8Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

Yiming Sun1*, Yutong Xue1*, Ruoyang Shao, MD, PhD1*, Zhiping Fan2*, Ren Lin2*, Fen Huang1*, Na Xu1* and Hua Jin3*

1Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
2Nanfang Hospital, Southern Medical University, Guangzhou, China
3Department of Hematology, Nanfang Hospital of Southern Medical University, Guangzhou, China

Yadith Karina Lopez-Garcia, MD1, Sara Redondo Velao, MD2*, Andres Gomez-De Leon, MD1, Irene García-Cadenas, MD2*, Héctor Alejandro Vaquera Alfaro, MD3, Perla R. Colunga-Pedraza, MD1, Albert Esquirol, MD2*, César Homero Gutierrez-Aguirre, MD3*, José Carlos Jaime-Pérez, MD1*, Jorge Sierra, MD2, Olga Cantu, MD3*, Javier Briones2*, David Gomez-Almaguer, MD3 and Rodrigo Martino, MD2*

1Servicio de Hematología, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Universidad Autónoma de Nuevo León, Monterrey, Mexico
2Hematology and Hemotherapy Department, Hospital de la Sant Creu i Sant Pau. IIB-Sant Pau and José Carreras Leukemia Research Institutes. Universitat Autónoma de Barcelona, Barcelona, Spain
3Servicio de Hematología, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Universidad Autónoma de Nuevo León, Monterrey, NL, Mexico

Arjun Pandey1*, Ivan Pasic, MD2*, Igor Novitzky-Basso, MD2*, Arjun Law, MD2, Wilson Lam, MD2, Fotios Michelis, MD2*, Armin Gerbitz, MD, PhD3*, Auro Viswabandya, MD2, Rajat Kumar, MD PhD2, Jonas Mattsson, MD, PhD4* and Dennis Dong Hwan Kim, MD, PhD2

1University of Toronto, Toronto, Canada
2Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada, Toronto, ON, Canada
3Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
4Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada

Jingbo Yu, MD, PhD1*, Kristin J. Moore, PhD, MPH2*, Nicole M Engel-Nitz3*, Mary DuCharme, MLIS2*, John Galvin, MD, MPH4,5, Valkal Bhatt, PharmD1* and Catherine J. Lee, MD, MSc6

1Incyte Corporation, Wilmington, DE
2Optum, Eden Prairie, MN
3Optum, Inc., Eden Prairie
4Northwestern Medical Faculty Foundation, Chicago, IL
5Senior Medical Director, Incyte Corporation, Wilmington, DE
6Fred Hutchinson Cancer Center, University of Washington, Seattle, WA

Sachin Punatar, MD, DM1,2*, Lingaraj Nayak, MBBS, MD, DM2,3*, Niket Mantri, MD3*, Mukta Ramadwar, MD2,3*, Prachi Patil, MD, DM2,3*, Shaesta Mehta, MD, DM2,3*, Aditya Kale, MD, DM2,3*, Sridhar Epari, MD2,3*, Sridhar Sundaram, MD, DM2,3*, Koustubh Shekar, MD4*, Anant Gokarn, MD, DM2,5*, Akanksha Chichra, DNB2,3,6*, Sumeet Mirgh, MD, DM2,3*, Nishant Jindal, MD, MBBS2,7*, Kalpashree Deval8*, Libin Jacob Mathew3*, Bhausaheb Bagal, MD, DM2,9*, Hari Menon, MD, DM10 and Navin Khattry, MD, DM2,11*

1Department of Medical Oncology, Tata Memorial Centre, Navi Mumbai, India
2Homi Bhabha National Institute, Mumbai, India
3Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India
4Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai, India
5Tata Memorial Centre, Kharghar, Navi Mumbai, India., Navi Mumbai, India
6Department of Pediatric Oncology, Tata Memorial Centre, Mumbai, India
7Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Chandigarh, India, India
8BMT unit, ACTREC, Tata Memorial Centre, Navi Mumbai, India
9BMT unit, Department of Medical Oncology, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Homi Bhabha National Institute, Navi Mumbai, India
10St Johns National Academy of Health Sciences, Bengaluru, India
11Department of Medical Oncology, ACTREC, Tata Memorial Centre, Navi Mumbai, India

Stephanie J. Lee, MD, MPH1, Ningxin Ma, PhD2*, Timothy Randolph, PhD2*, Carrie L. Kitko, MD3, Corey S. Cutler, MD, MPH4, Najla El Jurdi, MD5,6, George Chen, MD7, Betty K. Hamilton, MD8, Joseph A. Pidala, MD, PhD9, Paul A Carpenter, MD2, Sally Arai, MD10, Lynn Onstad, MSc2*, Sophie Paczesny11, Tomoko Sekiguchi12*, Motoko Koyama, MD, PhD13 and Geoffrey R. Hill, MD12

1Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
2Fred Hutchinson Cancer Center, Seattle, WA
3Vanderbilt University Medical Center, Nashville, TN
4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
5Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, minneapolis, MN
6Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD
7Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
8Cleveland Clinic Foundation, Cleveland, OH
9Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
10Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA
11Medical University of South Carolina, Charleston, SC
12Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
13Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA

Florent Malard, M.D., Ph.D.1*, Michael Loschi, MD, PhD2*, Thomas Cluzeau, MD, PhD3*, Raynier Devillier, MD, PhD4*, Faezeh Legrand, MD5*, Amandine Charbonnier, MD6*, Delphine Lebon, MD7*, Anne Huynh, MD8*, Cecile Borel, MD9*, Jean-Baptiste Méar, MD10*, Faustine Lhomme, MD11*, Hélène Labussière-Wallet, MD12*, Déborah Desmier, MD13*, Niels Moya, MD14*, Martin Carré, MD15*, Jérôme Cornillon16*, Vincent Camus, MD, PhD17*, Patrice Ceballos, MD18*, Francesco Saraceni, MD19*, Corentin Orvain20*, Sylvain Chantepie, MD21*, Jakob Daniel Rudzki22*, Marie-Anne Couturier, MD23*, Patrice Chevallier, MD, PhD24, Clemence Mediavilla, MD25*, Gabrielle Roth-Guepin, MD26*, David Beauvais, MD27*, Etienne Daguindau, MD28*, Karin Bilger, MD29*, Stefan A. Klein, MD30*, Pedro Chorao, MD31*, Sarah Altmeyer, MD32*, Francesca Patriarca, MD33*, Marion Bruelle34*, Emilie Plantamura, PhD, MSc, PharmD35*, Gianfranco Pittari, MD PhD36* and Mohamad Mohty, MD, PhD37

1Sorbonne Université, Hôpital Saint-Antoine, AP-HP, Service d'Hématologie Clinique et Thérapie Cellulaire,Centre de Recherche Saint-Antoine UMRs938, Paris, France
2Hematology Department, Nice University Hospital, Nice, France
3Hematology Department, Nice University Hospital, Cote d’Azur University, Nice, France
4Hematology and Transplantation, Institut Paoli-Calmettes, Aix Marseille University, Marseille, France
5Hematology department, Institut Paoli calmettes, Marseille, FRA
6Clinical Hematology Department, Amiens-Picardie University Hospital, Amiens, France
7Service d’Hématologie Clinique, Centre Hospitalier Universitaire Amiens-Picardie, Amiens, FRA
8Hematology Department, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
9Service d'Hématologie, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
10Hematology Clinic, Rennes University Hospital, Rennes, France
11Clinical Hematology, University Hospital of Rennes, RENNES, France
12Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France
13Hematology and cellular therapy department, University Hospital of Poitiers, Poitiers, FRA
14Hematology department & CIC 1402, Poitiers University Hospital, Poitiers, France
15Département d'Hématologie, CHU de Grenoble Alpes, Grenoble, France
16Département d'hématologie Clinique et de Thérapie Cellulaire, CHU Saint-Etienne, Saint-Etienne, France
17Centre Henri Becquerel, Department of Hematology, Rouen, France
18Clinical Hematology Department, Montpellier University Hospital, Saint Eloi Hospital, MONTPELLIER, France
19Hematology and Stem Cell Transplant, Ospedali Riuniti Torrette di Ancona, Ancona, Italy
20Univ Angers, Nantes Université, CHU Angers, Inserm, CNRS, CRCI2NA, Angers, France
21Basse-Normandie Institute of Hematology, CHU de Caen, Caen, France
22Department for Hematology and Oncology, Internal Medicine V, Medical University Innsbruck (MUI), Innsbruck, Austria
23Department of Hematology, CHRU Brest, BREST, France
24Hematology Department, Nantes University Hospital, Nantes, France
25Hematology Department, CHU de Bordeaux, Bordeaux, France
26Department of Clinical Hematology, CHRU Nancy, Vandoeuvre Les Nancy, France
27Hematology Department., CHRU Lille, Lille, FRA
28Department of Clinical Hematology, Hopital Jean Minjoz, Service d'Onco-hématologie, Besançon, France
29Hematology, Institut de Cancerologie Strasbourg Europe (ICANS), Strasbourg, France
30Hämatologie und Onkologie, Medizinische Klinik, Universitaetsmedizin Mannheim, Mannheim, Germany
31Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
32Department of Oncology, Hematology, Clinical Immunology and Rheumatology, Saarland University Medical Center, Homburg/Saar, Germany
33Division of Hematology and Stem Cell Transplantation, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Udine, Italy
34MaaT Pharma, Lyon, AL, France
35MaaT Pharma, LYON, France
36MaaT Pharma, Lyon, France
37Sorbonne University, Hôpital Saint-Antoine, and INSERM UMRs938, Paris, France

Sophia Göldel1*, Tingting Zheng2,3*, Tina Eismann1*, Melanie Tiefgraber1*, Mats Urban1*, Alix Schwarz1*, Klaus Neuhaus2*, Mohsen Pourjam2*, Ilias Lagkouvardos2*, Elisabeth Meedt4*, Karin Kleigrewe5*, Julia Frank6*, Michael Neuenhahn6*, Dirk H Busch, MD6*, Peter Herhaus, MD7*, Mareike Verbeek, MD7*, Wolfgang Herr, MD4, Romana Gerner1*, Klaus-Peter Janssen8*, Simon M Heidegger, M.D1*, Florian Bassermann, MD9*, Hendrik Poeck, MD4, Melanie Schirmer2,3,10* and Erik Thiele-Orberg1,4*

1Hospital Rechts der Isar, Internal Medicine III - Hematology and Oncology, Technical University of Munich, Munich, Germany
2ZIEL – Institute for food and health, Technical University of Munich, Freising, Germany
3Translational Microbiome Data Integration, School of Life Sciences, Technical University of Munich, Freising, Germany
4Internal Medicine III - Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany
5Bavarian Center for Biomolecular Mass Spectrometry, Technical University of Munich, Freising, Germany
6Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany
7Department of Medicine III, Hematology and Oncology, Technical University of Munich (TUM), School of Medicine and Health, Munich, Germany
8Hospital Rechts der Isar, Department of Surgery, Technical University of Munich, Munich, Germany
9Department of Medicine III, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
10Center for Organoid Systems, Technical University of Munich, Garching, Germany

Yasser Khaled, MD1, Samer K Khaled, MD2, Juan Carlos Varela, MD PhD2*, Rachel Hatton, PharmD, BCOP2*, Hang Thanh Le Nguyen, RN2*, Sean Deygoo, RN2*, Brooke Adams, PharmD, BCOP2* and Megan Smith, MSN, APRN2*

1Orlando Health Cancer Institute, Bone Marrow Transplant and Cellular Therapy, Orlando, Fl
2Orlando Health Cancer Institute, Bone Marrow Transplant and Cellular Therapy, Orlando, FL

Manan Shah1, Rathan Kumar2, Lotus Neidemire-Colley3*, Mandi Zhu3*, Nicholas Yuhasz4*, Malith Karunasiri5*, Parvathi Ranganathan, PHD4* and Hannah Choe, MD6

1The James Cancer Hospital and Solove Research Institute, Ohio State University, Columbus
2The Ohio State University, Columbus, OH
3Ohio State University, Columbus
4Ohio State University, Columbus, OH
5the Ohio State University, Columbus
6Department of Internal Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital, Columbus, OH

Laura G.M. Daenen1*, Lotte Van Der Wagen2*, Edouard F. Bonneville3,4*, Lucia Lopez Corral, MD5*, Laimonas Griskevicius6*, Martin Bornhäuser, MD7*, Yves Beguin, MD8, Maija Itala-Remes9*, Jorinde D. Hoogenboom4*, Liesbeth C. de Wreede3*, Florent Malard10*, Christian Chabannon11, Francesco Dazzi12*, Annalisa Ruggeri, MD, PhD13* and Jurgen Kuball, MD14

1Hematology, UMC Utrecht, Utrecht, Netherlands
2Department of Hematology, University Medical Center, Utrecht, NLD
3Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands
4EBMT Leiden Study Unit, Leiden, Netherlands
5Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Salamanca, Spain
6Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania, Vilnius, Lithuania
7University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
8Centre Hospitalier Universitaire of Liège, University of Liege, Liege, BEL
9Turku University Hospital, Turku, Finland
10Department of Clinical Hematology and Cellular Therapy, Sorbonne University, Saint Antoine Hospital, Assistance Publique - Hôpitaux de Paris, INSERM UMRs 938, Centre de Recherche Saint-Antoine (CRSA), PARIS, France
11Centre de Thérapie Cellulaire. Institut Paoli-Calmettes Comprehensive Cancer Center & module Biothérapies du Centre d’Investigations Cliniques de Marseille, Inserm CBT-1409 Aix-Marseille Université, AP-HM, IPC. Marseille, Marseille, France
12School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, London, United Kingdom
13Hematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
14Department of Hematology, University Medical Centre, Utrecht, Netherlands

Piyanuch Kongtim, MD1*, Piyatida Chumnumsiriwath2*, Pongthep Vittayawacharin, MD1,3*, Deepa Jeyakumar, MD4, Benjamin Lee5*, Jean Doh, PharmD6*, Shawn P. Griffin, PharmD6*, Richard Van Etten, MD7* and Stefan O. Ciurea, MD1

1Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, Orange, CA
2Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, Bangkok, Thailand
3Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
4Department of Medicine, Division of Hematology Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine Health, University of California Irvine, Orange, CA
5University of California Irvine, Department of Pharmacy, Orange, CA
6Department of Pharmacy, University of California Irvine, Orange, CA
7Division of Hematology and Oncology, University of California Irvine, Hematopoietic Stem Cell Transplant and Cellular Therapy Program, Orange, CA

Edouard Forcade, MD, PhD1*, Raynier Devillier, MD, PhD2*, Jean-François Hamel, PhD3*, Jean-Baptiste Méar, MD4*, Claude-Éric Bulabois, MD5*, Jean-Henri Bourhis, MD, PhD6, Sylvain Chantepie, MD7*, Pascal Turlure, MD8*, Patrice Chevallier, MD, PhD9,10, Patrice Ceballos, MD11*, Bruno Lioure12*, Jacques-Olivier Bay, MD, PhD13*, Jean Valere Malfuson14*, Stéphanie Nguyen-Quoc, MD, PhD15*, Marianne Schwarz, MD16*, Jérôme Cornillon17*, Michael Loschi, MD, PhD18*, Mathieu Leclerc, MD, PhD19*, Marie-Thérèse Rubio, MD, PhD20*, Etienne Daguindau, MD21*, Natacha Maillard, MD22*, Amandine Charbonnier, MD23*, Nathalie Contentin, MD24*, Hélène Labussière-Wallet, MD25*, Alban Villate, MD26*, Ibrahim Yakoub-Agha, MD, PhD27*, Arnaud Pigneux, MD, PhD28*, Mathilde Hunault, MD, PhD29*, Christian Recher, MD, PhD30*, Hervé Dombret, MD, PhD31, Nicole Raus, RN32*, Marie Robin, MD33*, Jean-Yves Cahn, MD34*, Gerard Socie35, Anne Huynh, MD36* and Régis Peffault De Latour, MD, PhD37*

1Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, Bordeaux, France
2Hematology and Transplantation, Institut Paoli-Calmettes, Aix Marseille University, Marseille, France
3Biostatistics Department, CHU Angers, Angers, France
4BMT unit, CHU Rennes, Rennes, France
5Hematology Department, Grenoble University Hospital, Grenoble, France
6Gustave Roussy Cancer Campus, BMT Service, Department of Hematology, VILLEJUIF CEDEX, FRA
7Basse-Normandie Institute of Hematology, CHU de Caen, Caen, France
8Service d'Hématologie Clinique, CHU de Limoges, Limoges, France
9Hematology Department, Nantes University Hospital, Nantes, France
10Hematology Clinic, Nantes University Hospital, Nantes, France
11Clinical Hematology Department, Montpellier University Hospital, Saint Eloi Hospital, MONTPELLIER, France
12Hematology, Department of Hematology, University Hospital of Strasbourg Institut De Canc, Strasbourg, France
13CHU ESTAING, Clermont-Ferrand, France
14Centre des armées Percy, CLAMART CEDEX, FRA
15Hematology Department, Pitié-Salpêtrière University Hospital, AP-HP, Paris, France
16Centre Hospitalier Universitaire d’Angers, Angers, France
17Département d'hématologie Clinique et de Thérapie Cellulaire, CHU Saint-Etienne, Saint-Etienne, France
18CHU de Nice - Hôpital L'Archet 1, Nice, France
19Hematology Department, Henri Mondor University Hospital, AP-HP, Créteil, France
20Department of Hematology, Nancy University Hospital, Vandoeuvre Les Nancy, France
21Department of Clinical Hematology, Hopital Jean Minjoz, Service d'Onco-hématologie, Besançon, France
22Hematology Department, CHU de Poitiers, Poitiers, France
23Clinical Hematology Department, Amiens-Picardie University Hospital, Amiens, France
24Centre Henry Becquerel, Rouen, France
25Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France
26Hematology Department, Tours University Hospital, Tours, FRA
27Lille University Hospital, Lille, France
28Hématologie Clinique et Thérapie cellulaire, CHU Bordeaux, Bordeaux, France
29Hematology Clinic, Angers University Hospital, Angers, France
30Hematology Department, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
31Department of Hematology, Saint Louis University Hospital, AP-HP, Paris, France
32SFGM-TC coordination, Hôpital Lyon Sud, Lyon, FRA
33Hopital Saint Louis, APHP, Paris, France
34Hematology Department, CHU Grenoble, Grenoble, France
35Hematology and Transplant Unit, Saint Louis Hospital, APHP, Paris, France
36Department of Hematology and Bone marrow Transplantation, CHU Toulouse - Institut Universitaire du Cancer Toulouse – Oncopole, Toulouse, France
37Hopital St. Louis, Department of Hematology - BMT, Paris, France

Haiyan Zhang*, Qiaoyuan Wu*, Huajuan Dai*, Xinyu Liu*, Zhiping Fan*, Ren Lin*, Na Xu*, Qianwei Liu*, Qifa Liu, MD and Hua Jin*

Nanfang Hospital, Southern Medical University, Guangzhou, China

Robert J. Soiffer, MD1, Mitchell Horwitz, MD2, Joseph P. McGuirk, DO3, Sudhindra Rao, PhD4*, Peter Westervelt, MD5*, John F. DiPersio, MD, PhD6, Laura Johnston, MD7, Jonathan Serody, MD8, Witold B Rybka, MD9*, Paul Shaughnessy, MD10*, Joseph A. Pidala, MD, PhD11, Vincent Ho, MD12*, Andrew Artz, MD, MS13, Madhuri Vusirikala, MD14*, David L. Porter, MD15, Paul J. Martin, MD16, David Avigan, MD17, Michael R Bishop, MD18*, Ran Reshef, MD, MSc19, Andrew Peterson20*, Kwang Wooahn, PhD21,22*, Adetola A. Kassim, MBBS, MS23, Ryotaro Nakamura, MD24, Yi-Bin Chen, MD, MS25 and Linda Burns26*

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
2Duke University Medical Center, Durham, NC
3University of Kansas Medical Center, Westwood, KS
4CIBMTR, Wisconsin
5Washington University in Saint Louis, St. Louis
6Division of Oncology, Washington University School of Medicine, Saint Louis, MO
7Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA
8Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC
9PennState Health, Hershey
10Methodist Hospital, San Antonio
11Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
12450 Brookline Ave, Dana Farber Cancer Institute, Boston, MA
13City of Hope National Medical Center, Duarte, CA
14Actinium Pharmaceuticals, New York, NY
15Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
16Fred Hutchinson Cancer Center, Seattle, WA
17Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA
18The University of Chicago, Chicago
19Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY
20Medical College of Wisconsin, Milwaukee
21CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI, Milwaukee, WI
22Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI
23Vanderbilt University Medical Center, Nashville, TN
24Hematology and HCT, City of Hope National Medical Center, Duarte, CA
25Hematopoietic Cell Transplant and Cell Therapy Program, Massachusetts General Hospital, Boston, MA
26Center For International Blood and Marrow Transplant Research, Milwaukee, WI

Melhem M. Solh, MD1, Asad Bashey, MD, PhD1, Lawrence E Morris, MD1, Lizamarie Bachier-Rodriguez1*, H. Kent Holland, MD1*, Xu Zhang, PhD2*, Rajveer Singh3*, Katelin Jackson4* and Scott R. Solomon, MD1

1Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta, GA
2Center for Clinical and Transitional Sciences,, University of Texas, Houston, TX
3Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, atlanta, GA
4Northside Hospital Cancer Institute, Atlanta, GA

Melhem M. Solh, MD1, Asad Bashey, MD, PhD1, Michael T Aubrey2*, Brian Freed2*, Christina Roark2*, Lawrence E Morris, MD1, H Kent Holland3*, Lizamarie Bachier-Rodriguez1*, Xu Zhang, PhD4* and Scott R. Solomon, MD1

1Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta, GA
2University of Colorado Cord Blood Bank & Clinimmune Lab, Aurora, CO
3Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, atlanta, GA
4Center for Clinical and Transitional Sciences,, University of Texas, Houston, TX

Shayna Jankowski, BS1*, Shuhua Wang, MD1*, Yiwen Helen Li, MD2, Cynthia R. Giver, PhD3 and Edmund K. Waller, MD, PhD1,4

1Winship Cancer Institute, Emory University, Atlanta, GA
2Emory University School of Medicine, Atlanta, GA
3Emory University Winship Cancer Institute, Atlanta, GA
4Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA

Alicja Sadowska-Klasa, MD1,2, Łukasz Klasa2*, Szymon Wojtylak2,3*, Agnieszka Piekarska1*, Patryk Sobieralski1,2*, Jan Maciej Zaucha4,5* and Dariusz Wydra2,3*

1Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland
2University Clinical Center in Gdansk, Gdansk, Poland
3Medical University of Gdansk, Gdansk, Poland
4Department of Hematology and Bone Marrow Transplantation, Medical University of Gdańsk, Gdańsk, Poland
5Department of Haematology and Transplantology, Medical University of Gdańsk, Gdańsk, Poland

*signifies non-member of ASH